405 related articles for article (PubMed ID: 28882625)
1. Drug-induced bile duct injury.
Visentin M; Lenggenhager D; Gai Z; Kullak-Ublick GA
Biochim Biophys Acta Mol Basis Dis; 2018 Apr; 1864(4 Pt B):1498-1506. PubMed ID: 28882625
[TBL] [Abstract][Full Text] [Related]
2. Cholangiocytes in the pathogenesis of primary sclerosing cholangitis and development of cholangiocarcinoma.
Chung BK; Karlsen TH; Folseraas T
Biochim Biophys Acta Mol Basis Dis; 2018 Apr; 1864(4 Pt B):1390-1400. PubMed ID: 28844951
[TBL] [Abstract][Full Text] [Related]
3. Drug-induced Bile Duct Injury - A Short Review.
Dobreva I; Karagyozov P
Curr Drug Metab; 2020; 21(4):256-259. PubMed ID: 32310045
[TBL] [Abstract][Full Text] [Related]
4. Cholemic nephropathy - Historical notes and novel perspectives.
Krones E; Pollheimer MJ; Rosenkranz AR; Fickert P
Biochim Biophys Acta Mol Basis Dis; 2018 Apr; 1864(4 Pt B):1356-1366. PubMed ID: 28851656
[TBL] [Abstract][Full Text] [Related]
5. Mechanisms of cholangiocyte responses to injury.
Sato K; Meng F; Giang T; Glaser S; Alpini G
Biochim Biophys Acta Mol Basis Dis; 2018 Apr; 1864(4 Pt B):1262-1269. PubMed ID: 28648950
[TBL] [Abstract][Full Text] [Related]
6. Pathophysiologic implications of innate immunity and autoinflammation in the biliary epithelium.
Strazzabosco M; Fiorotto R; Cadamuro M; Spirli C; Mariotti V; Kaffe E; Scirpo R; Fabris L
Biochim Biophys Acta Mol Basis Dis; 2018 Apr; 1864(4 Pt B):1374-1379. PubMed ID: 28754453
[TBL] [Abstract][Full Text] [Related]
7. Bile acid receptors in the biliary tree: TGR5 in physiology and disease.
Deutschmann K; Reich M; Klindt C; Dröge C; Spomer L; Häussinger D; Keitel V
Biochim Biophys Acta Mol Basis Dis; 2018 Apr; 1864(4 Pt B):1319-1325. PubMed ID: 28844960
[TBL] [Abstract][Full Text] [Related]
8. Animal models of biliary injury and altered bile acid metabolism.
Mariotti V; Strazzabosco M; Fabris L; Calvisi DF
Biochim Biophys Acta Mol Basis Dis; 2018 Apr; 1864(4 Pt B):1254-1261. PubMed ID: 28709963
[TBL] [Abstract][Full Text] [Related]
9. Endpoints in the design of clinical trials for primary sclerosing cholangitis.
Ponsioen CY
Biochim Biophys Acta Mol Basis Dis; 2018 Apr; 1864(4 Pt B):1410-1414. PubMed ID: 28847513
[TBL] [Abstract][Full Text] [Related]
10. Pathophysiology and Diseases of the Proximal Pathways of the Biliary System.
Nakanishi Y; Saxena R
Arch Pathol Lab Med; 2015 Jul; 139(7):858-66. PubMed ID: 26125426
[TBL] [Abstract][Full Text] [Related]
11. [Drug-induced bile duct injury: progress and challenges].
Li DL
Zhonghua Gan Zang Bing Za Zhi; 2023 Apr; 31(4):339-344. PubMed ID: 37248973
[TBL] [Abstract][Full Text] [Related]
12. The role of macrophages in the development of biliary injury in a lipopolysaccharide-aggravated hepatic ischaemia-reperfusion model.
Reiling J; Bridle KR; Schaap FG; Jaskowski L; Santrampurwala N; Britton LJ; Campbell CM; Jansen PLM; Damink SWMO; Crawford DHG; Dejong CHC; Fawcett J
Biochim Biophys Acta Mol Basis Dis; 2018 Apr; 1864(4 Pt B):1284-1292. PubMed ID: 28709962
[TBL] [Abstract][Full Text] [Related]
13. MicroRNAs and extracellular vesicles in cholangiopathies.
Olaizola P; Lee-Law PY; Arbelaiz A; Lapitz A; Perugorria MJ; Bujanda L; Banales JM
Biochim Biophys Acta Mol Basis Dis; 2018 Apr; 1864(4 Pt B):1293-1307. PubMed ID: 28711597
[TBL] [Abstract][Full Text] [Related]
14. [Clinicopathologic features of drug-induced vanishing bile duct syndrome].
Ye LH; Wang CK; Zhang HC; Liu ZQ; Zheng HW
Zhonghua Gan Zang Bing Za Zhi; 2017 Apr; 25(4):317-320. PubMed ID: 28494557
[TBL] [Abstract][Full Text] [Related]
15. Pathological features of primary sclerosing cholangitis identified by bile proteomic analysis.
Rupp C; Bode KA; Leopold Y; Sauer P; Gotthardt DN
Biochim Biophys Acta Mol Basis Dis; 2018 Apr; 1864(4 Pt B):1380-1389. PubMed ID: 28943450
[TBL] [Abstract][Full Text] [Related]
16. Pathobiology of biliary epithelia.
Cheung AC; Lorenzo Pisarello MJ; LaRusso NF
Biochim Biophys Acta Mol Basis Dis; 2018 Apr; 1864(4 Pt B):1220-1231. PubMed ID: 28716705
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of intestinal bile acid absorption improves cholestatic liver and bile duct injury in a mouse model of sclerosing cholangitis.
Baghdasaryan A; Fuchs CD; Österreicher CH; Lemberger UJ; Halilbasic E; Påhlman I; Graffner H; Krones E; Fickert P; Wahlström A; Ståhlman M; Paumgartner G; Marschall HU; Trauner M
J Hepatol; 2016 Mar; 64(3):674-81. PubMed ID: 26529078
[TBL] [Abstract][Full Text] [Related]
18. A new xenobiotic-induced mouse model of sclerosing cholangitis and biliary fibrosis.
Fickert P; Stöger U; Fuchsbichler A; Moustafa T; Marschall HU; Weiglein AH; Tsybrovskyy O; Jaeschke H; Zatloukal K; Denk H; Trauner M
Am J Pathol; 2007 Aug; 171(2):525-36. PubMed ID: 17600122
[TBL] [Abstract][Full Text] [Related]
19. Role of the bicarbonate-responsive soluble adenylyl cyclase in cholangiocyte apoptosis in primary biliary cholangitis; a new hypothesis.
Chang JC; Go S; Verhoeven AJ; Beuers U; Oude Elferink RPJ
Biochim Biophys Acta Mol Basis Dis; 2018 Apr; 1864(4 Pt B):1232-1239. PubMed ID: 28962898
[TBL] [Abstract][Full Text] [Related]
20. Role of inflammation and proinflammatory cytokines in cholangiocyte pathophysiology.
Pinto C; Giordano DM; Maroni L; Marzioni M
Biochim Biophys Acta Mol Basis Dis; 2018 Apr; 1864(4 Pt B):1270-1278. PubMed ID: 28754451
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
